Real life triplet FIr/FOx chemotherapy in first line metastatic pancreatic ductal adenocarcinoma: Recommended schedule for expected activity and safety and phase II study

Authors :: R. Manetta
Enrico Ricevuto
Gemma Bruera
S. Carducci
Eugenio Ciacco
Aldo Victor Giordano
Silvia Massacese
Source :: Annals of Oncology. 29:v43
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
Schedule
Chemotherapy
Pancreatic ductal adenocarcinoma
business.industry
First line
medicine.medical_treatment
Phases of clinical research
Hematology
Internal medicine
medicine
business

Tools